FDA Helps to Deliver Meaningful Advances for Rare Disease Patients

We remain committed to supporting rare disease research, engaging patients and caregivers to understand their unique perspectives, and enhancing our review processes to advance medical products for rare disease patients.

Related Keywords

Robertm Califf , ,Health Care Professionals ,Clinical Research ,Drug Administration ,Office Of Orphan Products Development ,Sandy Retzky ,Orphan Products Development ,Disease Day ,Collaborative Effort Throughout ,Medical Product ,Trials Advancing Rare ,Rare Disease Day ,